Merrimack Pharmaceuticals (MACK) Earnings (2012 - 2024)
Merrimack Pharmaceuticals (MACK) earnings from Mar 31, 2012 to Mar 31, 2024. The TTM Merrimack Pharmaceuticals (MACK) earnings is $200M. You can adjust inflation or export chart.
Annual Earnings
Quarterly Earnings
Annual Earnings change of Merrimack Pharmaceuticals (MACK)
| Year | Earnings | Change |
|---|---|---|
| 2024 | $201M | -17165.25% |
| 2023 | -$1.18M | -23.38% |
| 2022 | -$1.54M | -37.14% |
| 2021 | -$2.45M | -19.14% |
| 2020 | -$3.03M | -82.52% |
| 2019 | -$17M | -57.22% |
| 2018 | -$41M | -108.60% |
| 2017 | $471M | -406.72% |
| 2016 | -$154M | +3.88% |
| 2015 | -$148M | +76.87% |
| 2014 | -$84M | -36.06% |
| 2013 | -$131M | +42.43% |
| 2012 | -$92M | N/A |